$FRSH

Lawrence Philippa sold $45K of FRSH

Lawrence Philippa (Chief Accounting Officer) sold 3,492 shares of Freshworks Inc. (FRSH) at $12.98 on 2026-10-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lawrence Philippa
Published Oct 5, 2026, 9:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 9:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FRSH
Bearish
medium confidence
Mentioned
$FRSH
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FRSHBearishLow
01

Why it matters

The disclosed sale is small relative to total shares outstanding, suggesting limited market impact.

02

Market read

Freshworks insider sale provides a modest data point for short-term traders but is unlikely to drive significant price movement.

03

What to watch

Potential tax planning or diversification needs for the insider, not necessarily a lack of confidence in the company.

Relevance 2/10Novelty 2/10Timing: today

Background

Form 4 filings disclose insider transactions and are primary sources for insider activity.

Company-level read

Ticker impact

$FRSHBearishMedium confidence
Context

Chief Accounting Officer sold 3,492 shares for $45,326 via a 10b5-1 plan on 2026-10-05.

Expected impact

likely modest selling pressure as the market prices the insider divestiture

Evidence & confidence

The transaction represents a small fraction of total holdings and is disclosed through a Form 4, indicating a routine liquidity event rather than a material concern.

Market effects

Minimal impact on the SaaS sector; insider sales are common and not indicative of broader trends.

No significant regional effect; the filing is specific to Freshworks.

Limited global relevance; only relevant to investors tracking Freshworks.

Counterpoint

The sale could be a routine liquidity move and not a negative signal; price may remain stable.

Key entities

  • Lawrence Philippa

    Chief Accounting Officer of Freshworks who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FRSHMed

Why Are Freshworks (FRSH) Shares Soaring Today

Freshworks (FRSH) shares rose 5.4% in pre-market trading after S&P Dow Jones Indices announced its addition to the S&P SmallCap 600, effective October 8, 2026. The company will replace BioLife Solutions, which is being acquired by Repligen. Freshworks is up 20.6% year-to-date, reaching a 52-week high of $13.99. However, long-term investors have seen a decline in value over five years.

$ZSHigh

Premarket movers: Constellation, Zscaler rise while Nike falls

U.S. stock futures rose on Tuesday, with Nasdaq Composite hitting a record high. Zscaler shares gained 2.2% after reaffirming fiscal 2027 revenue and earnings guidance. Nike shares fell 1% after a downgrade to Sell and a price target cut to $27.50. Vaxcyte stock dropped 3.7% following a $1 billion capital raise. Constellation Energy stock climbed 3% after a deal with Amazon and potential agreement with Google. Freshworks stock rose 3.9% after being added to the S&P SmallCap 600 index.

$FRSHHigh

Why is Freshworks stock climbing today?

Freshworks Inc. (FRSH) stock rose 3.9% in pre-market trading after being added to the S&P SmallCap 600 index, replacing BioLife Solutions. The move is driven by passive fund buying ahead of the October 8 rebalancing. Analysts have a consensus Buy rating with a $14.79 average price target. The broader market's positive tone and AI-driven software demand also support the stock's rally.

$FRSHHighAI 8/10

Freshworks to Replace BioLife Solutions in S&P SmallCap 600

S&P Dow Jones Indices announced Freshworks (FRSH) will replace BioLife Solutions (BLFS) in the S&P SmallCap 600 on October 8, 2026. Repligen (RGN) is acquiring BioLife for $1.5B, with BioLife shareholders receiving $11.25 per share in cash and 0.1442 shares of Repligen stock. Freshworks reported Q2 2026 revenue of $237.4M, up 16% YoY, and its first GAAP profitability in 2026.

$FRSHHighAI 8/10

Why is Freshworks stock rallying today?

Freshworks Inc. (FRSH) stock rose 4.4% in after-hours trading on Monday after being added to the S&P SmallCap 600 index, effective October 8. The stock traded at $13.80, near its 52-week high of $13.99. Analysts have a 'Moderate Buy' rating and an average price target of $14.46. The move was driven by index inclusion, not broader market trends.